The multikinase inhibitor RXDX-105 is effective against neuroblastoma<i>in vitro</i>and<i>in vivo</i>
Sean Flynn(University of California, San Diego), Peter E. Zage(Moores Cancer Center)
Cited by 11
Related Papers
mTOR ATP-competitive inhibitor INK128 inhibits neuroblastoma growth via blocking mTORC signaling
|APOPTOSIS|2014|49
Neuroblastoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2024|47
The Potential Functional Roles of NME1 Histidine Kinase Activity in Neuroblastoma Pathogenesis
|International Journal of Molecular Sciences|2020|42
USP7 Inhibition Suppresses Neuroblastoma Growth via Induction of p53-Mediated Apoptosis and EZH2 and N-Myc Downregulation
|International Journal of Molecular Sciences|2023|13